Canaccord Genuity analyst Sumant Kulkarni maintained a Buy rating on Voyager Therapeutics (VYGR – Research Report) yesterday and set a ...

Analyst Tim Chiang of Capital One Financial assigned a Buy rating on Jasper Therapeutics (JSPR – Research Report), with a price target of ...

Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for ...

In a recent study, mean sensitivity was 85.5% and specificity 87% for detection of clear-cell renal cell carcinoma ...

A new subgroup analysis of patients with muscle-specific tyrosine kinase (MuSK) autoantibody-positive (Ab+) myasthenia gravis ...

Topline interim results were announced from a trial evaluating sibeprenlimab for adults with immunoglobulin A nephropathy.

Researchers at WashU Medicine have reduced scar formation and improved heart function in mouse models of heart failure using a monoclonal antibody treatment. Untreated mice develop major scarring ...

A new study from Washington University School of Medicine in St. Louis suggests that a type of immunotherapy—similar to that ...

Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy ...

Q3 2024 Earnings Call Transcript October 22, 2024 Danaher Corporation beats earnings expectations. Reported EPS is $1.71, ...

Shares of Genmab A/S (OTCMKTS:GNMSF – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $266.48 and traded as low as ...